Pharmaceuticals, Biotechnology and Life Sciences
Former Chief Information officer and Executive Committee member for Bristol Myers Squibb brings deep industry and technology expertise to Science…
SAN CARLOS, Calif., Oct. 05, 2022 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on…
Dr. McHutchison will continue to provide strategic counsel as board member and chairman of the Science & Technology Committee of…
SEATTLE, Oct. 05, 2022 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that translates the…
PHILADELPHIA, Oct. 05, 2022 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived…
LONDON, Oct. 05, 2022 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that on September 30, 2022,…
PHILADELPHIA, Oct. 03, 2022 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) (“AnPac Bio” or the “Company”), a…
NEW YORK and SAN DIEGO, Oct. 03, 2022 (GLOBE NEWSWIRE) — Zentalis™ Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused…
NEW YORK, Oct. 02, 2022 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory…
BASEL, Switzerland, Oct. 02, 2022 (GLOBE NEWSWIRE) — Myovant Sciences Ltd. (NYSE: MYOV) (the “Company”) confirmed today that it has…